Saxena M, Madabhavi I, Patel A, Panchal H, Anand A. Experience of Sorafenib as First-Line Treatment in Metastatic Renal Cell Carcinoma in a Tertiary Care Centre. Int J Hematol Oncol Stem Cell Res. 2018;12(3):196-202.